News: Communications on Safety
Communications on Safety
YesImportant Medicine Safety Information_Golimumab SIMPONI® 50 mg: Important Changes to the Instructions For Use (IFU) for the SmartJect® Autoinjector/Pre-filled Pen
Important Medicine Safety Information_IMBRUVICA® (IBRUTINIB) - RISK OF FATAL CARDIAC EVENTS
Important Medicines Safety Information_COVID-19 Vaccine Janssen 26 October 2021
Important Announcement: IMBRUVICA
Important Medicine Safety Information_Golimumab SIMPONI® 50 mg: Important Changes to the Instructions For Use (IFU) for the SmartJect® Autoinjector/Pre-filled Pen